CHO Cells News and Research

RSS
Study reveals how lipids control SH2 domain-mediated cellular protein interactions

Study reveals how lipids control SH2 domain-mediated cellular protein interactions

ONR researcher explores how explosive shock waves contribute to traumatic brain injury

ONR researcher explores how explosive shock waves contribute to traumatic brain injury

Research proposes new contract scheme for flu vaccine distribution

Research proposes new contract scheme for flu vaccine distribution

A more effective method for detecting metastatic prostate cancer

A more effective method for detecting metastatic prostate cancer

Collaborative team to determine mechanisms that cause traumatic brain injuries due to shockwaves

Collaborative team to determine mechanisms that cause traumatic brain injuries due to shockwaves

Complix signs agreement with Selexis to advance production of autoimmune drug candidate CMX-02

Complix signs agreement with Selexis to advance production of autoimmune drug candidate CMX-02

Simple self-rating of health accurately predicts susceptibility to common cold

Simple self-rating of health accurately predicts susceptibility to common cold

Nucala (mepolizumab) approved for treatment of asthma patients

Nucala (mepolizumab) approved for treatment of asthma patients

PSMA PET imaging more precise than MR imaging for detection of high-grade prostate cancer lesions

PSMA PET imaging more precise than MR imaging for detection of high-grade prostate cancer lesions

CrystalGenomics signs agreement with Dong-A ST for commercialization of Acelex (polmacoxib) in Korea

CrystalGenomics signs agreement with Dong-A ST for commercialization of Acelex (polmacoxib) in Korea

Elsevier, NCI implement two-way linking between research articles on ScienceDirect and datasets in caNanoLab

Elsevier, NCI implement two-way linking between research articles on ScienceDirect and datasets in caNanoLab

Researchers develop new implantable drug-delivery system using nanowire

Researchers develop new implantable drug-delivery system using nanowire

Merus and Selexis receive a € 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer

Merus and Selexis receive a € 2.1 million grant for single cell line manufacturing of a bispecific antibody combination to treat colorectal cancer

Risk factors predict geographic atrophy after anti-VEGF treatment of RAP

Risk factors predict geographic atrophy after anti-VEGF treatment of RAP

Austrian Centre of Industrial Biotechnology develops method to reduce production costs of valuable drugs

Austrian Centre of Industrial Biotechnology develops method to reduce production costs of valuable drugs

BeiGene chooses SAFC's CHOZN Platform to support oncology drug development

BeiGene chooses SAFC's CHOZN Platform to support oncology drug development

Possible therapies to address cognitive symptoms in individuals with schizophrenia

Possible therapies to address cognitive symptoms in individuals with schizophrenia

Three hospitals jointly accredited as FIFA Medical Centre of Excellence

Three hospitals jointly accredited as FIFA Medical Centre of Excellence

Lintec to commercialize carbon nanotubes developed at UTD

Lintec to commercialize carbon nanotubes developed at UTD

New studies aim to help doctors, patients, and policymakers understand cancer prognosis, survival

New studies aim to help doctors, patients, and policymakers understand cancer prognosis, survival

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.